Jyn Erso is a fictional character in the Star Wars franchise, portrayed by English actress Felicity Jones as the main protagonist in the 2016 film Rogue One: A Star Wars Story.

2016年4月7日 · Jyn Erso, known by the aliases Kestrel Dawn, Jyn Dawn, Tanith Ponta, Liana Hallik, Lyra Rallik, and Nari McVee, was a human female soldier and former criminal who became a pivotal member of the Alliance to Restore the Republic when she led Rogue One in stealing the Death Star plans during the...

Jyn Erso is the protagonist of Lucasfilm's 2016 Star Wars spin-off film Rogue One. She was once a lonesome criminal until she was recruited by Rebellion to join in their fight against the Empire. During the Empire's reign of tyranny, Jyn Erso had a troubling life from the age of fifteen.

2022年3月10日 · We recently reported ErSO, a compound that induces ERα-dependent cancer cell death through a mechanism distinct from clinically approved ERα drugs, via hyperactivation of the anticipatory unfolded protein response. ErSO has remarkable tumor-eradicative activity in multiple ERα+ tumor models.

We recently reported ErSO, a compound that induces ERα-dependent cancer cell death through a mechanism distinct from clinically approved ERα drugs, via hyperactivation of the anticipatory unfolded protein response. ErSO has remarkable tumor-eradicative activity in multiple

Putting behind a checkered past by lending her skills to a greater cause, Jyn Erso is impetuous, defiant, and eager to bring the battle to the Empire. Used to operating alone, she finds higher purpose by taking on a desperate mission for the Rebel Alliance.

Jyn Erso is the main protagonist of the movie Rogue One: A Star Wars Story. A human female, she was a high-ranking member as well as a soldier in the Rebel Alliance and the leader of the Rogue One team. Erso played a critical role in stealing the plans for the Death Star from the Galactic Empire, sacrificing her life to ensure the successful ...

2022年10月14日 · erso是er+乳腺癌细胞中未折叠蛋白反应（upr）的小分子激活剂。 转移性ER+乳腺癌治疗急需创新型疗法的出现，ERSO的差异化作用机制使其有可能为此类患者提供重要的创新治疗选择。

美国伊利诺伊大学香槟分校的研究团队在 Science Translational Medicine 发表最新研究 A small-molecule activator of the unfolded protein response eradicates human breast tumors in mice ，研究指出，此次研究发现的新型分子化合物 ErSO 能与乳腺癌细胞上的雌激素受体结合，增强癌细胞 …

2021年8月12日 · 新发现的小分子化合物erso，具有选择性乳腺癌细胞杀伤作用，且只对雌激素受体（erα）阳性的乳腺癌有效。 erso对初治和内分泌治疗耐药的erα阳性乳腺癌均有效。 erso对原位和转移的erα阳性乳腺癌均有效，包括脑转移的乳腺癌。